Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04329325
Title Blinatumomab and Tyrosine Kinase Inhibitor Therapy in People With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Memorial Sloan Kettering Cancer Center
Indications

acute lymphoblastic leukemia

Therapies

Dasatinib + Dexamethasone + Methotrexate

Blinatumomab + Dasatinib + Methotrexate

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Mount Sinai Hospital Not yet recruiting New York New York 10029 United States Details
Memorial Sloan Kettering Cancer Center Recruiting New York New York 10065 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field